Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research

User menu

  • My alerts

Search

  • Advanced search
Life Science Alliance
  • Other Publications
    • EMBO Press
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Rockefeller University Press
    • Journal of Cell Biology
    • Journal of Experimental Medicine
    • Journal of General Physiology
    • Journal of Human Immunity
    • Cold Spring Harbor Laboratory Press
    • Genes & Development
    • Genome Research
  • My alerts
Life Science Alliance

Advanced Search

  • Home
  • Articles
    • Newest Articles
    • Current Issue
    • Methods & Resources
    • Author Interviews
    • Archive
    • Subjects
  • Collections
  • Submit
    • Submit a Manuscript
    • Author Guidelines
    • License, Copyright, Fee
    • FAQ
    • Why submit
  • About
    • About Us
    • Editors & Staff
    • Board Members
    • Licensing and Reuse
    • Reviewer Guidelines
    • Privacy Policy
    • Advertise
    • Contact Us
    • LSA LLC
  • Alerts
  • Follow LSA on Bluesky
  • Follow lsa Template on Twitter
Research Article
Transparent Process
Open Access

SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters

Prabhuanand Selvaraj, View ORCID ProfileChristopher Z Lien, Shufeng Liu, Charles B Stauft, Ivette A Nunez, Mario Hernandez, Eric Nimako, Mario A Ortega, Matthew F Starost, View ORCID ProfileJohn U Dennis, View ORCID ProfileTony T Wang  Correspondence email
Prabhuanand Selvaraj
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Z Lien
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher Z Lien
Shufeng Liu
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles B Stauft
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivette A Nunez
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Hernandez
2Division of Veterinary Services, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Nimako
2Division of Veterinary Services, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario A Ortega
2Division of Veterinary Services, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew F Starost
3Division of Veterinary Resources, Diagnostic and Research Services Branch, National Institutes of Health, Rockville Pike, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John U Dennis
2Division of Veterinary Services, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John U Dennis
Tony T Wang
1Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tony T Wang
  • For correspondence: tony.wang@fda.hhs.gov
Published 11 February 2021. DOI: 10.26508/lsa.202000886
  • Article
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Viral load and histopathological changes in female Syrian hamsters intranasally challenged with SARS-CoV-2

    .(A) Weight change profiles of hamsters that have been intranasally infected by indicated doses of SARS-CoV-2 USA/WA1-2020. (B) Subgenomic viral mRNA (sgmRNA) detected in nasal washes of SARS-CoV-2 challenged hamsters (N = 3) on 2, 5, 7 dpi. (C, D) SgmRNA and viral RNA (vRNA) (D) detected in nasal washes and the lungs of SARS-CoV-2–challenged hamsters (N = 6) on 3 dpi. (E, F) vRNA and sgmRNA detected in various organs of SARS-CoV-2–challenged hamsters (N = 4) on 5 dpi. The detection limit (25 copies for sgmRNA and 100 copies for vRNA per reaction) was shown with the dotted line. (G, H, I, J) Hematoxylin and eosin (H&E) staining of the lungs of 105 TCID50 SARS-CoV-2–challenged hamsters on 2, 5, and 7 dpi. (K, L, M, N) Lung tissues from hamsters challenged with indicated doses of virus were estimated for the percentage of consolidated areas. Scale bar in (G, H, I, J, K, L, M, N) = 500 μm. (O) Neutralizing antibody titers of each hamster at the end of the study. Blue dot denotes the hamster that received 100 TCID50; Green dot represents the hamster that received 10 TCID50.

  • Figure S1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S1. Histopathology of SARS-CoV-2 infected hamsters.

    (A, B, C) Nasal turbinates of uninfected and infected hamsters on 2 and 5 dpi. (B) White dotted circle in (B) indicates the immune cell infiltration. (C) White dotted circle in (C) shows the decrease in respiratory epithelial cells in the olfactory mucosa. Scale bar = 200 μm. (D, E, F, G) Trachea of uninfected or infected hamsters on 2, 5, and 7 dpi. Black arrows indicate areas with clear loss of cilia. (H, I, J, K) Lung tissues from uninfected and infected hamsters on 2, 5, and 7 dpi. Scale bar = 60 μm. (J, L) A close-up image taken from panel (J). Green arrows indicate macrophages; red arrows indicate neutrophils; an orange arrow points to a lymphocyte; blue arrows show fibrinous exudate and edema. (M, N, O) Brain tissues from uninfected and infected hamsters on 2 and 5 dpi. (P, Q, R) Olfactory bulbs from uninfected and infected hamsters on 2 and 5 dpi. Scale bar = 100 μm in (M, N, O, P, Q, R).

  • Figure S2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure S2. Efficient SARS-CoV-2 transmission in Syrian hamsters through close contact.

    (A) Male Syrian hamsters (4–8 wk old) upon intranasal inoculation of SARS-CoV-2 of 105 TCID both had weight loss for up to 7 d (A). (B) Serum neutralizing antibody titers of four hamsters on 7 dpi. (C) A representative image of the consolidated region in the lung of infected hamster on 7 dpi. Scale bar = 50 μm. (D) protein fluid in airways on 7 dpi. Scale bar = 20 μm. (E) Atypical pneumocyte hyperplasia. There is also alveolar airway hemorrhage, alveolar airway proteinaceous fluid accumulation, bronchiolar mucosa hyperplasia, lumina contain foamy macrophages with fewer lymphocytes and neutrophils, a mild lymphoplasmacytic infiltrate of the interstitium, a few hyaline membranes, necrosis, and loss of terminal bronchiole mucosa. Scale bar = 50 μm. (F) perivascular lymphocytes and bronchiolar hyperplasia. Scale bar = 20 μm. (G) All lobes of the lung of the contact hamster developed consolidated regions. (H) Atypical pneumocyte hyperplasia in the lung of the contact hamster on 7 dpi. (I, J) RNAScope images of the lungs from either uninfected (I) or the contact hamster (J). The top panels show the whole lung and the bottom images are representative close-ups. The viral genomic RNA is shown as reddish dots. Scale bar = 200 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Prolonged virus replication in nasal cavity of aged Syrian hamsters.

    (A) Weight change profile of aged hamsters after intranasal inoculation of 105 TCID50 SARS-CoV-2 isolate USA-WA1/2020. The date of birth was indicated to the right of each hamster ID. WH031 and 32 represent negative controls inoculated with media. (B) Clinical scores of hamsters. Y-axis represents day post-infection (dpi). Day 0 is the day when inoculum was given. X-axis represents the animal ID with WH031 and 032 being uninfected control. (C) Breathing rate was counted by two independent observers and averaged. (D) sgmRNA levels in uninfected (black solid circles) and infected hamsters (colored solid circles) on 2,5,7,9,14 dpi. (A) Each color corresponds to the same colored animal ID in (A). (E) Pathology of the heart of the hamster that died. The thrombus formation was noticed in the left atrium (indicated by white arrows and a small black box) with a closeup image shown to the right. Scale bar = 200 μm. (F) Pathology of the lung of the hamster that succumbed to infection. Scale bar: left = 5 mm; right = 60 μm. (G, H, I) RNAscope images of the uninfected hamster lung (negative), the lung and the brain of WH036. Red dots indicate the presence of viral genomic RNA. (G, H, J) Scale bar: 200 μm in (G), 60 μm in (H), 300 μm in (J). (J) Survival curves of four aged hamsters.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Post-infection immunity protects re-challenge.

    (A) Overall study design of the study. 10 hamsters Fig 1A recovered from infection were reinoculated with 105 TCID50 SARS-CoV-2 isolate USA-WA1/2020 on Day 28 post primary infection. (B) Neutralizing antibody titers of each hamster at the time of re-inoculation. (C) Weight change profile of all re-inoculated hamsters. (D) sgmRNA detected from nasal washes collected on 0, 1, 2, 3, and 7 dpi. (E) Virus titers of nasal washes collected from first (red) and second (green) infections. (F) Viral RNA (red) and sgmRNA levels (blue) in the lungs on 3, 7 dpi. (G) A representative HE image of the lung from a re-inoculated hamster. Scale bar = 60 μm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Post-infection immunity limits transmission.

    The overall study design is depicted in Fig 3A. Four hamsters were paired with four naïve hamsters in clean cages on Day 29 (1 d after re-inoculation) and then another two naïve hamsters on Day 30 (2 d after re-inoculation of the transmitters). Each cage housed two hamsters (one re-inoculated and one naïve). (A) Weight change profile of contact hamsters. (B, C) sgmRNA and viral RNA (C) in nasal washes collected on 0, 1, 2, 3, 5, and 7 d post-contact. (C) Red solid circles in (C) denote two contact hamsters which were exposed to hamsters that were without prior infection but challenged with 105 TCID50 virus. Black solid circles indicate contact those hamsters that were exposed to the re-challenged hamsters. (D) Viral loads detected in the lungs. (E) Representative HE images of the lung from a contact hamster. Scale bar = 200 μm. (F) Neutralizing antibody titers of each hamster at the end of the study.

PreviousNext
Back to top
Download PDF
Email Article

Thank you for your interest in spreading the word on Life Science Alliance.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters
(Your Name) has sent you a message from Life Science Alliance
(Your Name) thought you would like to see the Life Science Alliance web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prior infection of SARS-CoV-2 limits transmission
Prabhuanand Selvaraj, Christopher Z Lien, Shufeng Liu, Charles B Stauft, Ivette A Nunez, Mario Hernandez, Eric Nimako, Mario A Ortega, Matthew F Starost, John U Dennis, Tony T Wang
Life Science Alliance Feb 2021, 4 (4) e202000886; DOI: 10.26508/lsa.202000886

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prior infection of SARS-CoV-2 limits transmission
Prabhuanand Selvaraj, Christopher Z Lien, Shufeng Liu, Charles B Stauft, Ivette A Nunez, Mario Hernandez, Eric Nimako, Mario A Ortega, Matthew F Starost, John U Dennis, Tony T Wang
Life Science Alliance Feb 2021, 4 (4) e202000886; DOI: 10.26508/lsa.202000886
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
Issue Cover

In this Issue

Volume 4, No. 4
April 2021
  • Table of Contents
  • Cover (PDF)
  • About the Cover
  • Masthead (PDF)
Advertisement

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgements
    • References
  • Figures & Data
  • Info
  • Metrics
  • Reviewer Comments
  • PDF

Subjects

  • Microbiology, Virology & Host Pathogen Interaction

Related Articles

  • No related articles found.

Cited By...

  • Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera
  • Pathobiology and dysbiosis of the respiratory and intestinal microbiota in 14 months old Golden Syrian hamsters infected with SARS-CoV-2
  • Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model
  • Google Scholar

More in this TOC Section

  • HU modulates thiol–disulfide homeostasis
  • GSK3A, a proviral host factor for HAdV-B7 replication
  • PSME3 regulates myogenesis
Show more Research Article

Similar Articles

EMBO Press LogoRockefeller University Press LogoCold Spring Harbor Logo

Content

  • Home
  • Newest Articles
  • Current Issue
  • Archive
  • Subject Collections

For Authors

  • Submit a Manuscript
  • Author Guidelines
  • License, copyright, Fee

Other Services

  • Alerts
  • Bluesky
  • X/Twitter
  • RSS Feeds

More Information

  • Editors & Staff
  • Reviewer Guidelines
  • Feedback
  • Licensing and Reuse
  • Privacy Policy

ISSN: 2575-1077
© 2025 Life Science Alliance LLC

Life Science Alliance is registered as a trademark in the U.S. Patent and Trade Mark Office and in the European Union Intellectual Property Office.